SCHEMBL21708694

SCHEMBL21708694

CCCC(F)OC(=O)C(CN)c1c(F)cccc1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 3/20 0.37
TAS1R1 Q7RTX1 3/20 0.37
TSHR P16473 2/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
JAK2 O60674 1/20 0.34
HSP90AA1 P07900 1/20 0.34
RAB9A P51151 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PTGFR P43088 3/20 0.33
KMT2A Q03164 2/20 0.33
PDE4D Q08499 1/20 0.33
NPC1 O15118 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KAT6A Q92794 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708747 0.82 TAS1R3 (0.36) TAS1R3TAS1R1TSHRGABRA1GABRG2
SCHEMBL21632310 0.80 PTGFR (0.45) JAK2HSP90AA1RAB9ANPSR1PTGFR
SCHEMBL21656359 0.78 ITGA4 (0.40) JAK2HSP90AA1RAB9ANPSR1PTGFR
SCHEMBL21708677 0.75 ROCK2 (0.49) TAS1R3TAS1R1KDM4E
SCHEMBL21708781 0.74 KMT2A (0.39) TAS1R3TAS1R1TSHRNPSR1PTGFR
SCHEMBL21708758 0.72 ROCK2 (0.45) TAS1R3TAS1R1ALDH1A1
SCHEMBL21708613 0.72 TAS1R3 (0.33) TAS1R3TAS1R1PTGFR
SCHEMBL21708656 0.72 TAS1R3 (0.35) TAS1R3TAS1R1TSHRGABRA1GABRG2
SCHEMBL21708663 0.71 ROCK2 (0.44) TSHRNPSR1KMT2ANPC1SMN1; SMN2
SCHEMBL18782403 0.70 TAS1R3 (0.41) TAS1R3TAS1R1TSHRJAK2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed